China Designates BCI as National Strategy, First Commercial Device Approved
China has designated brain-computer interface technology as a key industry in its five-year plan, making it a national strategic priority. On the same day, a Shanghai startup received approval for NEO, a minimally invasive BCI device placed on the brain's protective membrane, claiming the world's first commercial invasive BCI ahead of Elon Musk's Neuralink.